Is antimicrobial resistance evolution accelerating?

Christopher Witzany; Sebastian Bonhoeffer; Jens Rolff

doi:10.1371/journal.ppat.1008905

Is antimicrobial resistance evolution accelerating?

PLoS Pathog. 2020 Oct 22;16(10):e1008905. doi: 10.1371/journal.ppat.1008905. eCollection 2020 Oct.

Authors

Christopher Witzany¹, Sebastian Bonhoeffer², Jens Rolff^{1

3}

Affiliations

¹ Freie Universität Berlin, Institut für Biologie, Evolutionary Biology, Berlin, Germany.
² Institute of Integrative Biology, ETH Zürich, Zürich, Switzerland.
³ Berlin-Brandenburg Institute of Advanced Biodiversity Research (BBIB), Berlin, Germany.

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Anti-Bacterial Agents / pharmacology*
Antimicrobial Cationic Peptides / metabolism*
Antimicrobial Cationic Peptides / pharmacology*
Drug Resistance, Bacterial / drug effects*
Evolution, Molecular
Humans

Substances

Anti-Bacterial Agents
Antimicrobial Cationic Peptides

Grants and funding

JR acknowledges funding from the Volkswagen Foundation (Grant number 96 517, https://www.volkswagenstiftung.de/en/funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.